당뇨병성 족부궤양 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 치료별, 궤양 유형별, 최종 사용자별, 지역별 부문, 경쟁(2020-2030년)
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment, By Ulcer Type, By End User, By Region and Competition, 2020-2030F
상품코드:1796902
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 당뇨병성 족부궤양 치료 시장 규모는 2024년에 55억 1,000만 달러로 평가되었고 예측 기간 중 CAGR은 7.45%를 나타낼 전망이며, 2030년에는 84억 8,000만 달러에 달할 것으로 예상됩니다.
세계의 당뇨병성 족부궤양 치료 시장은 건강에 해로운 식습관의 소비와 함께 앉아 없는 라이프스타일을 보내는 사람이 늘고 있는 것이 배경에 있어 큰 성장을 이루고 있습니다. 게다가 사람들의 미의식이 높아짐에 따라, 무통하고 저비용의 치료에 대한 수요 증가는 세계 각지에서 당뇨병성 족부궤양 치료 수요를 크게 높여주고 있습니다. 게다가 발 궤양과 같은 다양한 궤양 질환에 걸리기 쉬운 고령화 인구가 세계적으로 증가하고 있기 때문에 다양한 치과 윤곽 성형술에 대한 수요가 더욱 증가하여 시장 성장이 촉진될 것으로 예측됩니다. 또한 세계적으로 건강에 해로운 라이프스타일을 보내는 비만의 확산이 확대되고 있으며, 예측 기간 동안 당뇨병성 족부궤양 치료 시장을 더욱 지원할 것으로 기대되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
55억 1,000만 달러
시장 규모 : 2030년
84억 8,000만 달러
CAGR : 2025-2030년
7.45%
급성장 부문
생물학적 제제
최대 시장
북미
또한, 적절한 의료기기와 의약품의 사용이 증가함에 따라 당뇨병성 족부궤양 치료에 대한 수요가 더욱 증가하여 시장 성장을 지원할 것으로 예측됩니다. 미국 질병예방관리센터(CDC)에 따르면 미국에서는 18세 이상의 600만명이 당뇨병 예비군이고, 65세 이상의 2,640만명(48.8%)이 당뇨병 예비군입니다.
시장 성장 촉진요인
세계 당뇨병 유병률 상승
주요 시장 과제
개발 도상 지역의 고비용 및 상환 제한
주요 시장 동향
원격 의료와 원격 상처 모니터링의 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
치료별(상처 치료 드레싱, 생물학적 제제, 치료 기기, 항생제 등)
궤양 유형별(신경병증성 궤양, 허혈성 궤양, 신경허혈성 궤양)
최종 사용자별(병원 및 진료소, 외래 진료 센터, 기타)
지역별
기업별(2024년)
시장 맵
치료별
궤양 유형별
최종 사용자별
지역별
제6장 북미의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 당뇨병성 족부궤양 치료 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협/서비스
제14장 SWOT 분석 : 세계의 당뇨병성 족부궤양 치료 시장
제15장 경쟁 구도
3M Company
Medtronic Plc
ConvaTec, Inc.
Coloplast Corporation
Smith & Nephew Plc
B Braun Melsungen AG
Medline Industries, Inc.
Organogenesis, Inc.
Molnlycke Health Care AB
Acelity LP, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Diabetic Foot Ulcer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. The global market for Diabetic Foot Ulcer Treatment is experiencing significant growth, driven by the increasingly leading of sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe which is susceptible to different kinds of ulcer diseases like foot ulcers is further expected to increase the demand for different dental contouring procedures, thereby fuelling market growth. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.51 Billion
Market Size 2030
USD 8.48 Billion
CAGR 2025-2030
7.45%
Fastest Growing Segment
Biologics
Largest Market
North America
Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States and 26.4 million people aged 65 years or older (48.8%) have prediabetes.
Key Market Drivers
Rising Global Prevalence of Diabetes
One of the most significant drivers of the diabetic foot ulcer treatment market is the alarming rise in global diabetes prevalence. Diabetic foot ulcers are among the most serious complications of uncontrolled diabetes and often result in infection, hospitalization, or amputation if not properly managed. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021-a figure projected to rise to 783 million by 2045. A significant proportion of these individuals are at risk of developing foot ulcers at some stage due to peripheral neuropathy and vascular complications.
In response, national healthcare systems are actively scaling up preventive treatment strategies for diabetic complications. For instance, the Centers for Disease Control and Prevention (CDC) in the U.S. estimates that 15% of diabetic patients develop foot ulcers, and up to 25% may eventually require amputation if untreated. Many countries, including India, China, and Brazil-where diabetes rates are surging-have launched national diabetes control programs focusing on early detection and comprehensive wound care.
The growing diabetic population has led to an increase in the demand for advanced wound care products, offloading devices, and surgical interventions. Government-supported reimbursements for chronic wound management in public health systems across Europe and North America also encourage greater access to treatment. As a result, the diabetic foot ulcer treatment market is experiencing continuous growth due to the expanding patient base and escalating need for long-term management solutions.
Key Market Challenges
High Cost and Limited Reimbursement in Developing Regions
One of the key challenges impeding the growth of the DFU treatment market is the high cost of advanced wound care solutions, particularly in low- and middle-income countries (LMICs). Treatments such as NPWT, skin grafts, bioengineered skin substitutes, and HBOT often require specialized equipment and trained personnel, making them unaffordable for many patients. Unlike high-income countries, where public health systems cover most costs, LMICs often lack comprehensive insurance schemes that include chronic wound care. According to the World Bank, more than half the world's population lacks access to essential healthcare services, and out-of-pocket healthcare expenses push approximately 100 million people into extreme poverty annually. This financial barrier makes it challenging for many diabetic patients to pursue prolonged ulcer care, leading to complications and avoidable amputations.
Key Market Trends
Integration of Telemedicine and Remote Wound Monitoring
With the digital transformation of healthcare, telemedicine is emerging as a vital trend in diabetic foot ulcer treatment. Patients with DFUs often require frequent assessments to monitor wound progression, detect signs of infection, and adjust treatment plans. In rural or underserved areas, access to wound care specialists is limited, making telehealth a critical tool for continuous care. Governments are increasingly recognizing the potential of digital health solutions. For example, the U.S. Health Resources and Services Administration (HRSA) and similar agencies in Europe have expanded funding for remote chronic care management tools, including wound imaging apps and digital platforms that allow clinicians to evaluate ulcers remotely. These technologies enable early detection of complications, improve patient compliance, and reduce the need for hospital visits.
In countries like Australia and Canada, telemedicine platforms are being used to connect patients in remote regions with urban wound care centers, ensuring equitable access to expertise. Some platforms use AI to assess wound size, depth, and tissue characteristics, supporting data-driven treatment decisions. Furthermore, digital recordkeeping and remote prescriptions simplify follow-ups and allow multidisciplinary teams to coordinate care more effectively. As global digital health adoption grows, integrating wound care into telemedicine ecosystems will be an important advancement in improving treatment outcomes and patient satisfaction for DFUs.
Key Market Players
3M Company
Medtronic Plc
ConvaTec, Inc.
Coloplast Corporation
Smith & Nephew Plc
B Braun Melsungen AG
Medline Industries, Inc.
Organogenesis, Inc.
Molnlycke Health Care AB
Acelity L.P., Inc.
Report Scope:
In this report, the Global Diabetic Foot Ulcer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Diabetic Foot Ulcer Treatment Market, By Treatment:
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic Medications
Others
Diabetic Foot Ulcer Treatment Market, By Ulcer Type:
Neuropathic Ulcers
Ischemic Ulcers
Neuroischemic Ulcers
Diabetic Foot Ulcer Treatment Market, By End User:
Hospitals & Clinics
Ambulatory Care Centers
Others
Diabetic Foot Ulcer Treatment Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Diabetic Foot Ulcer Treatment Market.
Available Customizations:
Global Diabetic Foot Ulcer Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Diabetic Foot Ulcer Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
5.3.1. By Treatment
5.3.2. By Ulcer Type
5.3.3. By End User
5.3.4. By Region
6. North America Diabetic Foot Ulcer Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment
6.2.2. By Ulcer Type
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment
6.3.1.2.2. By Ulcer Type
6.3.1.2.3. By End User
6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment
6.3.2.2.2. By Ulcer Type
6.3.2.2.3. By End User
6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment
6.3.3.2.2. By Ulcer Type
6.3.3.2.3. By End User
7. Europe Diabetic Foot Ulcer Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By Ulcer Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment
7.3.1.2.2. By Ulcer Type
7.3.1.2.3. By End User
7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment
7.3.2.2.2. By Ulcer Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment
7.3.3.2.2. By Ulcer Type
7.3.3.2.3. By End User
7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment
7.3.4.2.2. By Ulcer Type
7.3.4.2.3. By End User
7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment
7.3.5.2.2. By Ulcer Type
7.3.5.2.3. By End User
8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By Ulcer Type
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment
8.3.1.2.2. By Ulcer Type
8.3.1.2.3. By End User
8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment
8.3.2.2.2. By Ulcer Type
8.3.2.2.3. By End User
8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment
8.3.3.2.2. By Ulcer Type
8.3.3.2.3. By End User
8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment
8.3.4.2.2. By Ulcer Type
8.3.4.2.3. By End User
8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment
8.3.5.2.2. By Ulcer Type
8.3.5.2.3. By End User
9. South America Diabetic Foot Ulcer Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By Ulcer Type
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment
9.3.1.2.2. By Ulcer Type
9.3.1.2.3. By End User
9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment
9.3.2.2.2. By Ulcer Type
9.3.2.2.3. By End User
9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment
9.3.3.2.2. By Ulcer Type
9.3.3.2.3. By End User
10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment
10.2.2. By Ulcer Type
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment
10.3.1.2.2. By Ulcer Type
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment
10.3.2.2.2. By Ulcer Type
10.3.2.2.3. By End User
10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment
10.3.3.2.2. By Ulcer Type
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. SWOT Analysis: Global Diabetic Foot Ulcer Treatment Market
